These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18822713)

  • 21. Radiosensitization in head and neck cancer: do we have an alternative to platins? Role of taxanes.
    Joseph B; Vishwanath L; Venugopal BK
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):324-8. PubMed ID: 24388535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
    Willey CD; Murphy BA; Netterville JL; Burkey BB; Shyr Y; Shakhtour B; Kish B; Raben D; Chen C; Song JI; Kane MA; Cmelak AJ
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1323-31. PubMed ID: 17289289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatment for head and neck cancer.
    FDA Consum; 2007; 41(2):5. PubMed ID: 17590894
    [No Abstract]   [Full Text] [Related]  

  • 24. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
    Bardet E; Bourhis J; Cals L; Fayette J; Guigay J; Hans S; Saint-Guily JL; Lagarde F; Lallemant B; Milano G; Rolland F; Lefebvre JL
    Bull Cancer; 2009 Oct; 96(10):1013-28. PubMed ID: 19744919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seduction by induction?
    Beitler JJ; Cooper JS
    J Clin Oncol; 2009 Jan; 27(1):9-10. PubMed ID: 19047301
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond detection: novel applications for PET imaging to guide cancer therapy.
    Rajendran JG; Mankoff DA
    J Nucl Med; 2007 Jun; 48(6):855-6. PubMed ID: 17536105
    [No Abstract]   [Full Text] [Related]  

  • 29. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
    Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
    Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
    J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer.
    Guntinas-Lichius O; Appenrodt S; Veelken F; Krug B
    Laryngoscope; 2006 Apr; 116(4):613-8. PubMed ID: 16585868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction chemotherapy in head and neck cancer.
    Adelstein DJ
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):689-98, v-vi. PubMed ID: 10494507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taxanes in combined-modality therapy for solid tumors.
    Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of induction chemotherapy for head and neck squamous cell carcinoma.
    Haigentz M; Cohen EE; Wolf GT; Strojan P; Eisbruch A; Ferlito A
    Oral Oncol; 2012 Nov; 48(11):1065-7. PubMed ID: 22981388
    [No Abstract]   [Full Text] [Related]  

  • 36. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Specenier P; Rasschaert M; Vroman P; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
    Am J Clin Oncol; 2011 Oct; 34(5):472-7. PubMed ID: 20938321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
    Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
    Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evidence-based medicine (EBM) for radiation therapy--head and neck cancer].
    Sakata K
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):334-8. PubMed ID: 12669389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.